Autobio Diagnostics Statistics
Total Valuation
SHA:603658 has a market cap or net worth of CNY 17.79 billion. The enterprise value is 14.74 billion.
| Market Cap | 17.79B |
| Enterprise Value | 14.74B |
Important Dates
The last earnings date was Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | Jun 1, 2026 |
Share Statistics
SHA:603658 has 571.42 million shares outstanding. The number of shares has increased by 0.73% in one year.
| Current Share Class | 571.42M |
| Shares Outstanding | 571.42M |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | -1.84% |
| Owned by Insiders (%) | 0.78% |
| Owned by Institutions (%) | 6.68% |
| Float | 160.86M |
Valuation Ratios
The trailing PE ratio is 18.07 and the forward PE ratio is 16.45. SHA:603658's PEG ratio is 9.17.
| PE Ratio | 18.07 |
| Forward PE | 16.45 |
| PS Ratio | 4.21 |
| PB Ratio | 2.03 |
| P/TBV Ratio | 2.14 |
| P/FCF Ratio | 27.69 |
| P/OCF Ratio | 15.51 |
| PEG Ratio | 9.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.01, with an EV/FCF ratio of 22.93.
| EV / Earnings | 14.82 |
| EV / Sales | 3.49 |
| EV / EBITDA | 10.01 |
| EV / EBIT | 14.41 |
| EV / FCF | 22.93 |
Financial Position
The company has a current ratio of 2.42, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.42 |
| Quick Ratio | 1.95 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.08 |
| Interest Coverage | 73.28 |
Financial Efficiency
Return on equity (ROE) is 11.67% and return on invested capital (ROIC) is 13.11%.
| Return on Equity (ROE) | 11.67% |
| Return on Assets (ROA) | 5.46% |
| Return on Invested Capital (ROIC) | 13.11% |
| Return on Capital Employed (ROCE) | 10.76% |
| Weighted Average Cost of Capital (WACC) | 4.21% |
| Revenue Per Employee | 741,058 |
| Profits Per Employee | 174,410 |
| Employee Count | 5,700 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.36 |
Taxes
In the past 12 months, SHA:603658 has paid 119.52 million in taxes.
| Income Tax | 119.52M |
| Effective Tax Rate | 10.58% |
Stock Price Statistics
The stock price has decreased by -24.62% in the last 52 weeks. The beta is -0.02, so SHA:603658's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -24.62% |
| 50-Day Moving Average | 32.63 |
| 200-Day Moving Average | 34.09 |
| Relative Strength Index (RSI) | 36.69 |
| Average Volume (20 Days) | 3,863,363 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603658 had revenue of CNY 4.22 billion and earned 994.14 million in profits. Earnings per share was 1.72.
| Revenue | 4.22B |
| Gross Profit | 2.79B |
| Operating Income | 1.02B |
| Pretax Income | 1.13B |
| Net Income | 994.14M |
| EBITDA | 1.47B |
| EBIT | 1.02B |
| Earnings Per Share (EPS) | 1.72 |
Balance Sheet
The company has 3.20 billion in cash and 52.31 million in debt, with a net cash position of 3.15 billion or 5.51 per share.
| Cash & Cash Equivalents | 3.20B |
| Total Debt | 52.31M |
| Net Cash | 3.15B |
| Net Cash Per Share | 5.51 |
| Equity (Book Value) | 8.77B |
| Book Value Per Share | 15.18 |
| Working Capital | 3.24B |
Cash Flow
In the last 12 months, operating cash flow was 1.15 billion and capital expenditures -504.62 million, giving a free cash flow of 642.72 million.
| Operating Cash Flow | 1.15B |
| Capital Expenditures | -504.62M |
| Depreciation & Amortization | 442.77M |
| Net Borrowing | -114.11M |
| Free Cash Flow | 642.72M |
| FCF Per Share | 1.12 |
Margins
Gross margin is 66.13%, with operating and profit margins of 24.22% and 23.54%.
| Gross Margin | 66.13% |
| Operating Margin | 24.22% |
| Pretax Margin | 26.75% |
| Profit Margin | 23.54% |
| EBITDA Margin | 34.70% |
| EBIT Margin | 24.22% |
| FCF Margin | 15.22% |
Dividends & Yields
This stock pays an annual dividend of 1.31, which amounts to a dividend yield of 4.01%.
| Dividend Per Share | 1.31 |
| Dividend Yield | 4.01% |
| Dividend Growth (YoY) | 3.97% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 75.57% |
| Buyback Yield | -0.73% |
| Shareholder Yield | 3.28% |
| Earnings Yield | 5.59% |
| FCF Yield | 3.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHA:603658 is 38.19, which is 22.64% higher than the current price. The consensus rating is "Buy".
| Price Target | 38.19 |
| Price Target Difference | 22.64% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 9.87% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 27, 2021. It was a forward split with a ratio of 1.3.
| Last Split Date | May 27, 2021 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHA:603658 has an Altman Z-Score of 5.7 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.7 |
| Piotroski F-Score | 6 |